Skip to content
Your trusted source for high-purity research peptides — every lot HPLC & MS verified.
Verified Bioscience Compounds
PE 22-28
10MG
Research Use OnlyNot For Human Consumption
LYOPHILIZED POWDER
PE 22-28 10mg research vial — lyophilized powder, research use only, not for human consumption

HPLC ≥99% · Mass-spec confirmed · Lot-matched COA

Metabolic Research

PE 22-28 10mg

PE-22-28 is a nootropic peptide under research for its potential anxiolytic, antidepressant, and neuroprotective properties.

SKU
PE_22_28_10MG
Form
Lyophilized powder
Contents
Pack of 1
Purity
99%

Storage: lyophilized −20°C · reconstituted 2–8°C, protect from light

Select size

Price

$49.99

In stock · ships in 24h

HPLC tested

Lot-matched COA

US ships in 24h

PE-22-28 is a synthetic peptide based on the loop 1 domain of a neurotrophic factor, being studied for its potential applications in neurological research.

Researchers are investigating PE-22-28's capacity to influence neuronal function and survival, which could have implications for understanding various central nervous system conditions. Its development stems from efforts to create compounds that can mimic the beneficial effects of endogenous neurotrophic factors with improved pharmacokinetic properties.

Mechanism of Action

Research suggests that PE-22-28 may exert its effects by interacting with specific neurotrophin receptors, particularly TrkB, acting as a partial agonist. This interaction could lead to the activation of intracellular signaling pathways involved in neuronal plasticity, survival, and differentiation. It is hypothesized that by modulating these pathways, PE-22-28 can support neuronal health and function under various conditions.

Structure and Class

PE-22-28 is a short synthetic peptide, derived from the functional loop region of human brain-derived neurotrophic factor (BDNF). It belongs to a class of peptidomimetics designed to selectively target common neurotrophin receptors. Its small size allows for potential advantages in stability and tissue penetration compared to larger protein-based neurotrophic factors.

Primary Research Areas

The primary research areas for PE-22-28 include investigations into its neuroprotective properties, its role in cognitive function, and its potential to mitigate neuronal damage in various research models of neurological disorders. Researchers are also exploring its ability to promote synaptic plasticity and improve learning and memory in animal studies.

Notable Peer-Reviewed Findings

In studies involving animal models, PE-22-28 has been observed to improve cognitive performance and exhibit antidepressant-like effects. For instance, research has shown that PE-22-28 administration can enhance spatial learning and memory in rodent models. Furthermore, investigational studies have indicated its potential to protect neurons from various forms of stress and injury.

Metabolic Research

Metabolic research applications

Compounds in this class are studied for their effects on energy balance, glucose homeostasis, and lipid metabolism in laboratory models.

  • Glucose-stimulated insulin secretion and GLP-1/GIP/glucagon receptor signaling
  • Adipocyte differentiation, lipolysis, and mitochondrial bioenergetics
  • Appetite, satiety, and gastric-emptying assays in preclinical models
  • Body-composition and metabolic-rate endpoints in research cohorts

For laboratory research use only · not for human or veterinary use

Researcher reviews

No reviews yet — be the first.

Sign in to review
For laboratory research use only. Not for human or veterinary consumption. Not for diagnostic, therapeutic, or any in vivo use. Buyer assumes all responsibility and risk of use.

PE 22-28 10mg

$49.99